20, 40 eller 80 mg/ dag på LDL- kolesterol, VLDL- kolesterol, non- HDL- kolesterol, HDL- kolesterol, apolipoproteiner (apos) B, A- I, E, C- III og fibrinogen, (4) effekterne af 20, 40 eller 80 mg/ dag på lipoprotein restmetabolisme og (5) tolerabiliteten af simvastatin ved doser på 20, 40 eller 80 mg/ dag.
(1) the triglycerides-lowering efficacy of 20, 40, or 80mg/ day doses; (2) the effect of baseline triglycerides levels on triglycerides-lowering efficacy; (3) the effects of simvastatin 20, 40, or 80 mg/ day on LDL cholesterol, VLDL cholesterol, non-HDL cholesterol, HDL cholesterol, apolipoproteins (apos) B, A-I, E, C-III, and fibrinogen; (4) the effects of simvastatin 20, 40, or 80 mg/ day on lipoprotein remnant metabolism; and (5) the tolerability of simvastatin at doses of 20, 40, or 80 mg/ day.